©The Author(s) 2025.
World J Gastroenterol. Oct 7, 2025; 31(37): 110942
Published online Oct 7, 2025. doi: 10.3748/wjg.v31.i37.110942
Published online Oct 7, 2025. doi: 10.3748/wjg.v31.i37.110942
Table 2 Esophagogastroduodenoscopic findings, n (%)
| n (%) | |
| Organic EGD findings | |
| Gastric ulcer | 91 (0.4) |
| Duodenal ulcer | 29 (0.1) |
| Reflux esophagitis (≥ Los A) | 1240 (5.3) |
| Esophageal cancer | 27 (0.1) |
| Gastric cancer | 180 (0.8) |
| History of gastric surgery | 277 (1.2) |
| Gastric atrophy | |
| Non-eradicated atrophic gastritis | 7407 (31.9) |
| Atrophic changes post-eradication | 6868 (29.5) |
| No atrophic changes observed | 8977 (38.6) |
- Citation: Suzuki S, Kanno T, Koike T, Chiba T, Asanuma K, Kato K, Hatayama Y, Ogata Y, Saito M, Hatta W, Uno K, Imatani A, Masamune A. Epidemiology of dyspepsia and esophagogastroduodenoscopic findings in the era of Helicobacter pylori eradication. World J Gastroenterol 2025; 31(37): 110942
- URL: https://www.wjgnet.com/1007-9327/full/v31/i37/110942.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i37.110942